loader image
Sunday, November 30, 2025
58 F
McAllen
- Advertisement -

Gout: How Probiotics Can Help Alleviate Flare-Ups

Health & Lifestyle
215

Translate to Spanish or other 102 languages!

More than 41 million people worldwide have gout — a chronic arthritic condition causing pain, stiffness, and swelling of the joints. Image for illustration purposes
More than 41 million people worldwide have gout — a chronic arthritic condition causing pain, stiffness, and swelling of the joints. Image for illustration purposes

Medical News Today

- Advertisement -
  • More than 41 million people globally have gout. 
  • There is currently no cure for gout. 
  • Researchers from the Complutense University of Madrid have found a specific probiotic that helps lower the number of gout episodes a person has and gout-related drugs they have to take.

More than 41 million people worldwide have gout — a chronic arthritic condition causing pain, stiffness, and swelling of the joints.

Follow the link below to Medical News Today to read the full Story:

https://www.medicalnewstoday.com/articles/gout-probiotics-can-help-alleviate-flare-ups

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Untangling the Mystery of Sleep
Next article
Preventing Tick Bites

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×